Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07126275 · ClinicalTrials.gov registry record · NA
Mirror Journaling App Study
A NA study of Anxiety Symptoms and Depression Symptoms, sponsored by Child Mind Institute.
- Active
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 1
- Study location
NCT07126275: Active NA study of Anxiety Symptoms and Depression Symptoms, sponsored by Child Mind Institute.
NCT07126275 is a NA study of Anxiety Symptoms and Depression Symptoms that is active but no longer recruiting, run by Child Mind Institute. The registered enrollment target is 500 participants, above the 86-participant average among 5 other Anxiety Symptoms trials with a reported enrollment target (481% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07126275, a NA study of Anxiety Symptoms and Depression Symptoms, is active but no longer recruiting, sponsored by Child Mind Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
This study has three primary aims: 1) Validate Mirror's Mood Check feature by measuring convergent validity;2) Assess user experience and acceptability metrics (e.g., usability, engagement, satisfaction) of the Mirror app, with a particular focus on the journaling feature; 3) Assess the impact of guided journaling and mood tracking on depressive and anxious symptoms.
Primary Outcome
Statistical models including ANOVA and regression will be used to compare changes in depressive symptoms across the four groups. Changes in depressive symptoms will be assessed with the PROMIS Depression Short Form, which has scores that range from 8-40, with higher scores indicating greater depressive symptom severity. PROMIS was measured at baseline, post-intervention (8 weeks), and at a 1-month follow-up. PHQ-8 was administered at baseline as a screening instrument to determine eligibility a
Conditions Studied
Interventions
- DEVICE Mirror App Journaling and Mood Tracking Study
Study Locations (1)
New York
- Child Mind Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2025-03-12 |
| Est. Completion | 2026-08 |
| Phase | NA |
What the registry record for NCT07126275 still lists
NCT07126275 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 86-participant average among 5 other Anxiety Symptoms trials with a reported enrollment target (481% higher).
The record links to 2 conditions, with Anxiety Symptoms appearing as the primary indexed condition, and to 1 intervention - of which Mirror App Journaling and Mood Tracking Study is the first listed.
NCT07126275 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07126275 about?
NCT07126275 is a clinical study titled "Mirror Journaling App Study". This study has three primary aims: 1) Validate Mirror's Mood Check feature by measuring convergent validity;2) Assess user experience and acceptability metrics (e.g., usability, engagement, satisfaction) of the Mirror app, with a particular focus on the journaling feature; 3) Assess the impact of gu...
What is the current status of trial NCT07126275?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2025-03-12. Estimated completion is 2026-08.
What conditions does trial NCT07126275 study?
This clinical trial studies the following conditions: Anxiety Symptoms, Depression Symptoms.
What interventions are being tested in trial NCT07126275?
The interventions under investigation include: Mirror App Journaling and Mood Tracking Study (DEVICE).
Who is sponsoring clinical trial NCT07126275?
This trial is sponsored by Child Mind Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07126275 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety Symptoms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Video-feedback Intervention to Promote Racial-Ethnic Socialization Competency (VIP-RACE)
RECRUITING · NA
-
Strengthening Health and Insight in New Educators
RECRUITING · NA
-
Unmute's CARE Framework: A Novel Approach to Strengthen the Therapeutic Alliance and Reduce Treatment Disparities
ACTIVE NOT RECRUITING · NA
-
Effects of a Single-session Implicit Theories of Personality Intervention on Early Adolescent Psychopathology
COMPLETED · NA
-
Attachment and Biobehavioral Catch-up for Depression
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI